Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4749186 | 5867316 | I | 4749186-X | 20050101 | 20050224 | 20050817 | EXP | 216869 | GENENTECH, INC. | M | N | 20050816 | OT | ISRAEL |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4749186 | 1006337936 | PS | MABTHERA (RITUXIMAB) CONC FOR SOLUTION FOR INFUSION | 2 | INTRAVENOUS | 890 UNK, 1/MONTH, INTRAVENOUS | U | U | |||
| 4749186 | 1006358356 | SS | FLUDARABINE PHOSPHATE | 1 | INTRAVENOUS | 33.5 UNK,3/MONTH, INTRAVENOUS | U | U | |||
| 4749186 | 1006358365 | SS | CYCLOPHOSPHAMIDE | 1 | INTRAVENOUS | 335 UNK, 3/MONTH, INTRAVENOUS | U | U |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4749186 | 1006337936 | CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 4749186 | 1006358356 | CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 4749186 | 1006358365 | CHRONIC LYMPHOCYTIC LEUKAEMIA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4749186 | OT |
| 4749186 | RI |
Reactions reported
| Event ID | PT |
|---|---|
| 4749186 | FEBRILE NEUTROPENIA |
| 4749186 | PAROTITIS |
| 4749186 | WHITE BLOOD CELL COUNT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4749186 | FGN |
| 4749186 | HP |
| 4749186 | OTH |
| 4749186 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4749186 | 1006337936 | 20041222 | |||
| 4749186 | 1006358365 | 20041222 |